LAM561 With RT and TMZ for Adults With Glioblastoma

NCT04250922 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Glioblastoma
Glioblastoma Multiforme

Interventions

DRUG: LAM561
DRUG: TMZ
RADIATION: RT

Sponsor

Laminar Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]